Lamb CA, Sebastian S, Kent AJ, Segal JP, et al. Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Aliment Pharmacol Ther 2021;53:1236-1240.
PMID: 33961708